Assessing Barriers to Pharmacy Access Funding

Managing Risk in Research & Evaluation Initiatives Under the Pharmacy Leadership Scholars Grant Program The Pharmacy Leadership Scholars grant program, funded by the Banking Institution, is designed to support early-stage pharmacist researchers. As applicants navigate the complexities of this funding opportunity, understanding the risk landscape is crucial for successful project execution and securing the up to $10,000 grant. ### Regulatory Compliance and Risk Mitigation One key regulation that applies to research involving human subjects, which could be pertinent to projects under this grant, is the Common Rule (45 CFR 46), a set of regulations governing the ethical conduct of research involving humans. Compliance with this regulation is critical for minimizing the risk of non-compliance and ensuring that research is conducted ethically. For instance, projects that involve evaluating new pharmacy practices or interventions may need to adhere to these guidelines. Applicants must be aware of the necessity to obtain Institutional Review Board (IRB) approval for their research protocols, a process that can be time-consuming and requires careful planning. ### Unique Delivery Challenges in Research & Evaluation A verifiable delivery challenge unique to the Research & Evaluation sector is the difficulty in ensuring the reliability and validity of evaluation findings, particularly in complex healthcare settings. Pharmacy practice research often involves assessing the impact of interventions in real-world settings, where numerous variables can affect outcomes. This challenge necessitates robust study designs and methodologies to isolate the effects of the intervention being evaluated. Applicants should be prepared to articulate how they will address these challenges, potentially by leveraging mixed-methods approaches or collaborating with experts in research methodology. The Pharmacy Leadership Scholars grant program seeks to address diversity, equity, and inclusion in healthcare through innovative research. As such, applicants must be aware of the market shifts and policy priorities that are driving funding decisions in this area. There is a growing emphasis on research that can inform practice and policy changes to improve healthcare outcomes for diverse populations. Applicants should demonstrate an understanding of these trends and how their proposed research aligns with them. Capacity requirements for conducting rigorous research and evaluation include access to relevant data, expertise in research design and methods, and the ability to engage stakeholders throughout the research process. ### Operational Considerations and Resource Requirements Delivering a successful research or evaluation project under this grant requires careful planning and management. Staffing needs may include principal investigators with content expertise, methodologists, data analysts, and potentially project coordinators. Resource requirements can encompass access to literature databases, data analysis software, and potentially, participant incentives for studies involving human subjects. Workflow considerations include developing a detailed project timeline, milestones for deliverables, and regular check-ins with stakeholders. Eligibility barriers and compliance traps are significant risks for applicants. For example, failure to meet the eligibility criteria, such as being an early-stage pharmacist researcher, can result in disqualification. Similarly, non-compliance with the funding agency's regulations or terms of the grant award can lead to funding being withheld or revoked. Applicants must be diligent in ensuring their proposals are compliant with all requirements and that they have a plan in place for managing grant funds appropriately. ### Measurement and Reporting Requirements The Banking Institution will likely require grantees to report on specific outcomes and KPIs related to their research projects. For Research & Evaluation projects, this could include metrics related to the rigor of the research methodology, the significance of the findings, and the potential impact on pharmacy practice or policy. Applicants should be prepared to outline their plans for measuring and reporting on these outcomes. This includes understanding the NSF's or NIH's reporting requirements if their research is related to SBIR grants or national science foundation grants. For those applying to the Pharmacy Leadership Scholars grant, several FAQs are pertinent: Q: How do I ensure my research proposal complies with the Common Rule if I'm not sure whether my project involves human subjects research? A: To ensure compliance, consult with your institution's IRB or research office. They can provide guidance on whether your project is considered human subjects research and what steps you need to take to comply with the Common Rule. Q: What are some strategies for addressing the challenge of ensuring the reliability and validity of my evaluation findings? A: Consider employing robust study designs, such as randomized controlled trials where feasible, or mixed-methods approaches that combine quantitative and qualitative data. Collaboration with a research methodologist can also enhance the rigor of your evaluation. Q: Can I still be eligible for the Pharmacy Leadership Scholars grant if I'm not currently affiliated with a research institution? A: Eligibility criteria should be carefully reviewed. While affiliation with a research institution may be beneficial for accessing resources and support, it's not the sole determinant of eligibility. Focus on demonstrating how your research aligns with the grant's objectives and how you plan to conduct rigorous research despite the potential lack of institutional affiliation.